anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

223,681-223,740 of 319,975

filter-aware
03
Uses an infinity loop diagram to represent a continuous process or cycle of learning.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Interest1 hit
04
The slide highlights the pharmacodynamic (PD) effect of background corticosteroids in the placebo group, which was unexpected.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · InterestLoop · Aha Moment1 hit
05
The slide uses a circular portrait montage to humanize the 'transformation' message.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide outlines a clinical trial protocol using a process flow diagram.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations 1 hit
07
The slide presents a clinical trial outcome summary for the ADDRESS study.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Satisfaction1 hit
08
The slide uses a process-oriented visual layout to map strategic pillars to specific operational achievements.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Satisfaction1 hit
09
The slide uses a background image of the ocean with a digital network overlay, typical of biotech corporate branding.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Desire1 hit
01
Slide 1
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
02
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
03
The slide uses a structured list format to present key company pillars.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
04
Uses a two-column comparison for Sepsis vs Septic Shock, followed by two rows of key metrics.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a process flow diagram to contrast time-to-diagnosis and a bar chart to illustrate the exponential mortality risk of delayed treatment.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
Uses a before-after-bridge framing to contrast current lab processes with the proposed solution.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
The slide uses a two-column layout to contrast the platform hardware with the consumable cartridges.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a problem-solution framing, identifying the biomarker's potential and the specific pain point (time-sensitivity) that the Symphony IL-6 assay solves.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The slide highlights the superior NPV of IL-6 compared to standard biomarkers using a table and an ROC curve.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a horizontal bar chart to represent progress through Research, Development, Clinical Testing, and Regulatory stages.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
The slide emphasizes the clinical value of rapid turnaround time in critical care settings.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Includes a specific capital requirement estimate at the bottom.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
13
The slide uses a bottom-up market sizing approach based on patient volumes and testing frequency.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
14
The table compares 7 distinct operational metrics between the Bluejay Symphony and competitors (Beckman, Siemens, Roche).Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
15
Uses a stepped growth diagram to illustrate the commercialization roadmap.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
16
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
17
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
18
Includes both internal cash position and public market trading data for BJSX.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · Financial Highlights1 hit
19
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
20
Bluejay | Investor Presentation Deck | 20 slidesBluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
01
Slide 1
Comera | Investor Presentation Deck | 16 slidesComera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations 1 hit
02
Comera | Investor Presentation Deck | 16 slidesComera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations 1 hit
03
Comera | Investor Presentation Deck | 16 slidesComera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations 1 hit
04
Uses a visual metaphor of fluid dynamics (beakers and spheres) to explain viscosity reduction.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a hub-and-spoke visual structure to categorize benefits by stakeholder group.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
06
Includes a callout highlighting J&J's Darzalex Faspro achieving 85% conversion in under 2 years.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
07
The slide uses a hub-and-spoke diagram to illustrate the integration of three core components: Expert Engineering, Viscosity Reducing Excipients, and Computational Modeling.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
08
The slide features a screenshot of a specific scientific paper as evidence of peer-reviewed validation.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
09
The slide highlights a 77% viscosity reduction for Infliximab and a 45-78% reduction for Ipilimumab.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
10
The slide features two distinct research papers from the Journal of Pharmaceutical Sciences, showcasing data on viscosity reduction (infliximab, ipilimumab) and pharmacokinetic studies.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
11
Includes three distinct data panels: bar chart for viscosity, line charts for stability (SEC and IEX), and a dose-response curve for potency.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
12
The table uses green checkmarks for Comera and grey checkmarks for competitors, highlighting Comera's unique combination of all three advantages.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Golden Circle1 hit
13
Comera | Investor Presentation Deck | 16 slidesComera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Golden Circle1 hit
14
The slide lists 11 US patents and 12 international patents, totaling 23 distinct patent identifiers.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Golden Circle1 hit
15
Includes a screenshot of a press release and a callout box with key takeaways.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations 1 hit
16
Comera | Investor Presentation Deck | 16 slidesComera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations 1 hit
01
Slide 1
D-Wave | Investor Presentation Deck | 28 slidesD-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Attention1 hit
02
D-Wave | Investor Presentation Deck | 28 slidesD-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Attention1 hit
03
D-Wave | Investor Presentation Deck | 28 slidesD-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Attention1 hit
04
The slide uses a modular layout to present four distinct pillars of company strength.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Interest1 hit
05
The chart uses a stacked area visualization to show cumulative growth across different industry verticals.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
06
The slide uses a circular grid layout to present six distinct value propositions.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
07
The slide uses a hub-and-spoke style diagram to categorize mathematical problem types into three buckets, then maps them to quantum computing modalities.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
08
The slide uses a dual-track timeline to contrast D-Wave's specific product history with the general industry's gate-model development.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
09
The slide uses a mix of bulleted statistics and circular callouts for key metrics.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
10
The visual uses a Venn-like diagram with overlapping circular nodes connected by line patterns.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Desire1 hit
11
The visual uses a hub-and-spoke style diagram with interconnected circular nodes representing the three focus areas.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Desire1 hit
12
D-Wave | Investor Presentation Deck | 28 slidesD-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Desire1 hit
13
The slide highlights a specific customer success story with quantitative results.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Desire1 hit
14
The slide highlights a specific client success story (IPG) demonstrating efficiency gains.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Desire1 hit
15
The slide features a testimonial/case study format with a specific performance metric.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Desire1 hit
16
The slide highlights a specific client success story with quantitative results.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Desire1 hit
17
D-Wave | Investor Presentation Deck | 28 slidesD-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit